Winthrop Professor Gerald F Watts is a leading authority in cardiometabolic medicine, serving as a Senior Academic in the School of Medicine at The University of Western Australia and Senior Consultant Physician at Royal Perth Hospital. A graduate of Imperial College London, his academic and clinical training in medicine and cardiovascular medicine has distinguished his career in cardiometabolic medicine and research. Professor Watts has authored over 800 scientific publications, including landmark studies in coronary disease, dyslipidaemia, and novel gene silencing therapies. His work has shaped international best practice for managing familial hypercholesterolaemia (FH), as exemplified by his leadership of the FH Australasia Network and several national and international patient registries. He has received several awards, including the 2022 RT Hall Prize from the Cardiac Society of Australia and New Zealand, a 2020 Lifetime Achievement Award from the Medical Research Foundation of Royal Perth Hospital, and the prestigious Myant Lecturer at HEART UK in 2024. He is Editor-in-Chief of Current Opinion in Endocrinology-Diabetes-Obesity and serves on the editorial boards of leading cardiology and lipidology journals. Professor Watts has attracted multiple competitive research grants and has led two Centres of Clinical Research Excellence. He has supervised over 60 students and early-career researchers, many now in senior academic and clinical roles. His ongoing clinical trials, leadership in international guidelines, and commitment to knowledge translation continue to improve care for people living with complex and high impact lipid disorders.

Winthrop Professor Gerald F Watts is a leading authority in cardiometabolic medicine, serving as a Senior Academic in the School of Medicine at The University of Western Australia and Senior Consultant Physician at Royal Perth Hospital. A graduate of Imperial College London, his academic and clinical training in medicine and cardiovascular medicine has distinguished his career in cardiometabolic medicine and research. Professor Watts has authored over 800 scientific publications, including landmark studies in coronary disease, dyslipidaemia, and novel gene silencing therapies. His work has shaped international best practice for managing familial hypercholesterolaemia (FH), as exemplified by his leadership of the FH Australasia Network and several national and international patient registries. He has received several awards, including the 2022 RT Hall Prize from the Cardiac Society of Australia and New Zealand, a 2020 Lifetime Achievement Award from the Medical Research Foundation of Royal Perth Hospital, and the prestigious Myant Lecturer at HEART UK in 2024. He is Editor-in-Chief of Current Opinion in Endocrinology-Diabetes-Obesity and serves on the editorial boards of leading cardiology and lipidology journals. Professor Watts has attracted multiple competitive research grants and has led two Centres of Clinical Research Excellence. He has supervised over 60 students and early-career researchers, many now in senior academic and clinical roles. His ongoing clinical trials, leadership in international guidelines, and commitment to knowledge translation continue to improve care for people living with complex and high impact lipid disorders.